Buy or sell Eureka Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Eureka Therapeutics Stock

Eureka Therapeutics is a biotechnology company focuses on an immunotherapies for the treatment of cancer.

About Eureka Therapeutics Stock

Eureka Therapeutics pursues innovations that will change the world. We develop technologies that advance the field of antibody therapeutics by increasing the efficacy and specificity of antibody drugs, and the expression level of antibody cell lines. Eureka also provides a wide array of contract research services available to other companies. These services center around cell line development and antibody production or purification.

Funding History

January 2007$1K
August 2007$1.2M
November 2008$1.7M
September 2014$21.0M
January 2018$60.0M

Management

Research Scientist

Shon Green

Founder, CEO

Cheng Liu

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Eureka Therapeutics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo